RJFSA
MTNB icon

Raymond James Financial Services Advisors’s Matinas BioPharma MTNB Stock Holding History

Raymond James Financial Services Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-220
Closed -$1.74K – 3521
2024
Q2 		$1.74K Buy
+220
New +$1.99K ﹤0.01% 3395
2020
Q4 		– Sell
-14,299
Closed -$548K – 3041
2020
Q3 		$548K Buy
14,299
+260
+2% +$10.3K ﹤0.01% 1900
2020
Q2 		$543K Sell
14,039
-2,000
-12% -$76.7K ﹤0.01% 1873
2020
Q1 		$481K Buy
16,039
+144
+0.9% +$8.7K ﹤0.01% 1578
2019
Q4 		$1.8M Buy
15,895
+1,020
+7% +$59.1K 0.01% 1216
2019
Q3 		$469K Sell
14,875
-518
-3% -$18.7K ﹤0.01% 1942
2019
Q2 		$659K Sell
15,393
-65
-0.4% -$3.12K ﹤0.01% 1741
2019
Q1 		$842K Sell
15,458
-960
-6% -$51.7K ﹤0.01% 1551
2018
Q4 		$488K Sell
16,418
-4,544
-22% -$178K ﹤0.01% 1685
2018
Q3 		$964K Buy
20,962
+5,392
+35% +$116K ﹤0.01% 1488
2018
Q2 		$338K Buy
15,570
+2,268
+17% +$65.5K ﹤0.01% 2158
2018
Q1 		$509K Buy
13,302
+104
+0.8% +$5.5K ﹤0.01% 1706
2017
Q4 		$765K Sell
13,198
-170
-1% -$10.9K ﹤0.01% 1465
2017
Q3 		$882K Buy
13,368
+421
+3% +$28.1K 0.01% 1389
2017
Q2 		$1.09M Buy
12,947
+86
+0.7% +$11.5K 0.01% 1209
2017
Q1 		$1.78M Buy
+12,861
New +$2.1M 0.01% 884

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Raymond James Financial Services Advisors's MTNB Position: Q3 2024 in Review

Raymond James Financial Services Advisors sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 220 shares — an estimated $1.74K sold.

Raymond James Financial Services Advisors first reported a position in MTNB in Q1 2017 and held it in 16 quarters. The position peaked at $1.8M in Q4 2019. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • Raymond James Financial Services Advisors reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 220 Matinas BioPharma shares in Q3 2024, an estimated $1.74K.
  • Raymond James Financial Services Advisors first reported a position in Matinas BioPharma in Q1 2017 and held it in 16 quarters.
  • Raymond James Financial Services Advisors's Matinas BioPharma position peaked at $1.8M in Q4 2019.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.